Skip to content
Clinical Trials – home
Research site

University Of Eastern Finland

Finland P. O. Box 1627, 70211 Kuopio, Finland

  • 1 trial recruiting
  • Dementia Alzheimer's type
  • Adult patients

About Specializations

University Of Eastern Finland in Kuopio, Finland specialises in clinical trials of conditions such as Dementia Alzheimer's type, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases Research

The University Of Eastern Finland Brain Research Unit is conducting clinical trials focused on nervous system diseases, with a strong emphasis on Alzheimer’s disease and related cognitive disorders. The studies are designed to assess whether new treatments can improve memory, thinking, and daily functioning, while also examining longer-term safety and tolerability in people living with early and mild-to-moderate stages of the disease.

  • Early and mild-to-moderate Alzheimer’s disease
  • Mild cognitive impairment and mild dementia of the Alzheimer’s type
  • Testing new therapies and evaluating treatment effectiveness

This research landscape reflects an active effort in Kuopio to advance care for neurodegenerative conditions and to better understand how emerging therapies may support cognition and function.

Psychiatry and Psychology Studies

Clinical research at this site also connects to psychiatry and psychology, especially where mental disorders overlap with cognitive decline and brain health. The trials are exploring whether novel medicines can improve overall cognitive performance and global functioning in people affected by Alzheimer’s-related impairment.

  • Cognitive impairment linked to Alzheimer’s disease
  • Functional decline in people with early memory disorders
  • Improving diagnostic and treatment outcomes for brain-related disorders

These studies highlight a broader interest in how brain and behavior-related conditions can be treated more effectively through innovative clinical research.

Neurodegenerative Disease Trials

Another important area of work at the Brain Research Unit is the study of amyotrophic lateral sclerosis. These trials are investigating whether new treatments can help people with both sporadic and familial forms of the disease, with attention to safety, tolerability, and potential clinical benefit over time.

  • Amyotrophic lateral sclerosis in sporadic and familial forms
  • Assessing new approaches for a serious progressive neurological disease
  • Supporting long-term treatment evaluation

Together, these studies show that the University Of Eastern Finland is contributing to research aimed at slowing disease impact and improving quality of life for patients with challenging neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
P. O. Box 162770211 KuopioFinland
Recruiting now
1 trial
Conditions studied
1

More sites in KuopioFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dementia Alzheimer's type

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Biogen Idec Research Limited
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Gsk4527226
  • Sponsor:Glaxosmithkline Research & Development Limited
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Biogen Idec Research Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.